Netherlands vs Türkiye: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Netherlands
- Türkiye
How they compare
Netherlands currently reports 135 Cases against 132 Cases in Türkiye, a difference of 3 Cases.
The two have swapped places 1 time across 44 shared years of data; in 1981 it was Türkiye ahead.
Netherlands ranks 2nd and Türkiye ranks 3rd of 7 countries.
Netherlands has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Netherlands | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 135.11 Cases | 3.33 Cases | 131.78 Cases | Netherlands |
| 1990s | 416.5 Cases | 28.8 Cases | 387.7 Cases | Netherlands |
| 2000s | 297.3 Cases | 45.5 Cases | 251.8 Cases | Netherlands |
| 2010s | 249.5 Cases | 101.5 Cases | 148 Cases | Netherlands |
| 2020s | 154.6 Cases | 84.4 Cases | 70.2 Cases | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Netherlands or Türkiye?
- Netherlands, at 135 Cases against 132 Cases in Türkiye as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Netherlands and Türkiye?
- 3 Cases, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Türkiye?
- 44 years are reported by both, from 1981 to 2024.
- How do Netherlands and Türkiye rank globally for communicable diseases — communicable disease incidence?
- Netherlands ranks 2nd and Türkiye ranks 3rd of 7 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.